...
首页> 外文期刊>International Journal of Pharmaceutics >Paclitaxel-loaded chitosan oligosaccharide-stabilized gold nanoparticles as novel agents for drug delivery and photoacoustic imaging of cancer cells
【24h】

Paclitaxel-loaded chitosan oligosaccharide-stabilized gold nanoparticles as novel agents for drug delivery and photoacoustic imaging of cancer cells

机译:载有紫杉醇的壳聚糖寡糖稳定的金纳米颗粒作为癌细胞药物递送和光声成像的新型试剂

获取原文
获取原文并翻译 | 示例
           

摘要

Polymer nanoparticles have gained significant attention as potential drug carriers for anticancer agents and molecular imaging. Biocompatible gold nanoparticles (AuNPs) were synthesized using chitosan oligosaccharide (COS) as a reducing and stabilizing agent and were subsequently loaded with paclitaxel (PTX) to demonstrate their use in drug delivery and photoacoustic imaging (PAI) of MDA-MB-231 cells. Paclitaxel-loaded chitosan oligosaccharide-stabilized gold nanoparticles (PTX-COS AuNPs) were spherical in shape with an average particle size of 61.86 +/- 3.01 nm. PTX-COS AuNPs showed sustained and pH-dependent drug release profiles and exhibited strong cytotoxic effect against MDA-MB-231 cells through the induction of apoptosis with improved reactive oxygen species (ROS) generation and altered mitochondrial membrane potential (MMP) level. The cellular internalization of PTX-COS AuNPs was proven by fluorescence microscopy as well as flow cytometry. PTX-COS AuNPs were also evaluated as a new class of optical contrast agents for photoacoustic imaging (PAI). To the best of our knowledge, this is the first report that describes the use of PTX-COS AuNPs as novel agents for drug delivery and PAI of cancer cells. These results exposed the promising potential of PTX-COS AuNPs in the field of drug delivery, molecular imaging, and cancer therapy in the near future. (C) 2016 Published by Elsevier B.V.
机译:聚合物纳米颗粒作为抗癌剂和分子成像的潜在药物载体受到了广泛关注。使用壳聚糖寡糖(COS)作为还原剂和稳定剂合成了生物相容性金纳米颗粒(AuNPs),随后将其负载紫杉醇(PTX)以证明其在MDA-MB-231细胞的药物递送和光声成像(PAI)中的用途。紫杉醇负载的壳聚糖寡糖稳定化金纳米颗粒(PTX-COS AuNPs)呈球形,平均粒径为61.86 +/- 3.01 nm。 PTX-COS AuNPs表现出持续的和pH依赖的药物释放曲线,并通过诱导细胞凋亡而对MDA-MB-231细胞表现出强大的细胞毒性作用,并具有改善的活性氧(ROS)生成和改变的线粒体膜电位(MMP)水平。通过荧光显微镜和流式细胞术证明了PTX-COS AuNPs的细胞内在化。 PTX-COS AuNPs也被评估为用于光声成像(PAI)的新型光学对比剂。据我们所知,这是第一份描述PTX-COS AuNPs作为新型药物用于癌细胞的药物递送和PAI的报告。这些结果揭示了PTX-COS AuNP在不久的将来在药物输送,分子成像和癌症治疗领域的潜力。 (C)2016由Elsevier B.V.发布

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号